Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140323494 N-oxides of n-phenyl-2-pyrimidine-amine derivatives
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871506 Methods for treating cardio pulmonary diseases with NO group compounds
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/21/2014US8865202 Water soluble film for oral administration with instant wettability
10/21/2014US8865160 Treatment of disease conditions via administration of DNA repair enzyme
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140308269 Humanized antibodies
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/09/2014WO2014164736A1 Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/02/2014WO2014160768A1 Compositions and methods for preparing a subject for organ or non-organ implantation
10/02/2014WO2014158201A1 Compositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157672A1 Substituted biaryl compound
10/02/2014WO2014157623A1 Therapeutic agent for pulmonary hypertension, which contains benzophenone derivative or salt thereof
10/02/2014WO2014157429A1 Method for producing protein
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014155103A1 Taurine compositions suitable for inhalation
10/02/2014WO2014154727A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154726A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154725A1 Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
09/2014
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846607 Particles for treatment of pulmonary infection
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/25/2014WO2014152621A1 P2x7 modulators
09/25/2014WO2014152589A1 P2x7 modulators
09/25/2014WO2014152537A1 P2x7 modulators
09/25/2014WO2014152114A1 Heteroaromatic compounds as btk inhibitors
09/25/2014WO2014151620A1 5-thiazolecarboxamide dervatives and their use as btk inhibitors
09/25/2014WO2014151462A1 Novel breathing control modulating compounds, and methods of using same
09/25/2014WO2014151258A1 Substituted pyridine derivatives useful as c-fms kinase inhibitors
09/25/2014WO2014149526A1 Phenylephrine resinate particles
09/25/2014WO2014149525A1 Phenylephrine resinate particles and use thereof in pharmaceutical formulations
09/25/2014WO2014149301A1 Methods and non-immunogenic compositions for treating inflammatory disorders
09/25/2014WO2014149300A1 Treatment of inflammatory respiratory disease using biological solutions
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148455A1 Terpenoid derivative
09/25/2014WO2014146249A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140286878 Composition for inhalation
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/23/2014US8841307 Method of using diketopiperazines and composition containing them
09/23/2014CA2672261C Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin
09/23/2014CA2616222C Method for producing tiotropium salts comprising an esterification reaction of methylscopinium and a dithienyl derivative
09/23/2014CA2612264C Heterocyclylaminoalkyl substituted benzimidazoles
09/23/2014CA2608977C Antifungal agents
09/23/2014CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies
09/23/2014CA2546926C Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract
09/18/2014WO2014144860A1 Correctors acting through msd1 of cftr protein
09/18/2014WO2014142291A1 Hydrate of fluorine compound, and crystals thereof
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014142221A1 Drug for respiratory diseases
09/18/2014WO2014142084A1 METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY
09/18/2014WO2014140648A1 Drug combination
09/18/2014WO2014140647A1 Drug combination
09/18/2014WO2014140597A1 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromet hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors
09/18/2014WO2014140582A1 Kinase inhibitors
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014WO2014140091A1 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140075A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
09/18/2014WO2014138975A1 Preparation and method for use in the treatment of respiratory diseases
09/18/2014WO2014138907A1 Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/17/2014EP2777700A1 Method for ingesting creatine composition, creatine composition for use in said ingestion method, and creatine-containing medicinal agent and food each produced using said creatine composition
09/17/2014EP2776427A1 Modulators of atp-binding cassette transporters
09/17/2014EP2776426A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776425A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776393A1 Nampt inhibitors
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8834930 Pulmonary delivery of a fluoroquinolone
09/16/2014US8834900 Combination motif immune stimulatory oligonucleotides with improved activity
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014CA2624081C Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
09/16/2014CA2575513C Composition comprising a pulmonary surfactant and a tnf-derived peptide
09/12/2014WO2014137978A1 Treatment of lymphangioleiomyomatosis
09/12/2014WO2014135473A1 Inhibitors of bruton's tyrosine kinase
09/10/2014EP2774925A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters
09/10/2014EP2774623A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 878